Radiological heterogeneity in response to chemotherapy is associated with poor survival in patients with colorectal liver metastases

Radiological heterogeneity is present in approximately 35% of patients with CLM. Partial responders according to the RECIST criteria, show a significant poorer survival if classified as heterogeneous partial responder compared to homogeneous partial responders.